Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S420000, C546S070000, C544S233000, C544S247000, C514S248000, C514S257000, C514S285000
Reexamination Certificate
active
06872743
ABSTRACT:
A novel class of tetracyclic compounds represented by the formula Iwherein R1, R2, R3, R4, R5, R6, R7, A, B, C, D, E, and n are as defined is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.
REFERENCES:
patent: 0 950 657 (1999-10-01), None
patent: WO 9818464 (1998-05-01), None
Beight Douglas Wade
Kinnick Michael Dean
Lin Ho-Shen
Morin, Jr. John Michael
Richett Michael Enrico
Aulakh Charanjit S.
Eli Lilly and Company
Ginah Francis O.
LandOfFree
sPLA2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with sPLA2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and sPLA2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3448718